Juvelook Skin — one 30 mg vial for the whole face’s skin quality
Juvelook Skin is the newest dermal product in the range. How it differs from the original 50 mg Juvelook and who it suits. No prices or photos.
The short answer
Juvelook Skin is a 30 mg (25.5 mg PDLLA + 4.5 mg HA) dermal product launched by VAIM in June 2026. Its dose is set for one vial per person, injected into the dermis for overall skin quality — wrinkles, elasticity, pores and scars — using the patented porous mesh PDLLA particle. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu; +82 53-428-2700) stocks Juvelook Skin and uses it when the aim is whole-face texture in one go.
Specifications
| Item | Detail |
|---|---|
| Launch | June 2026 |
| Vial | 30 mg (25.5 mg PDLLA + 4.5 mg HA) |
| Layer | Dermis |
| Aims | Wrinkles, elasticity, pores, scars |
| Format | One vial per person |
| Approval | Tissue-repair material, class IV device; approved for temporary improvement of facial wrinkles in adults |
One vial, one person
Skin is sized so that one 30 mg vial is used for one person, opened at the time of treatment. That makes it clear exactly what went into your face.
We show the box and vial before treatment and the lot number if you wish.
What we use it for
- Whole-face texture and fine lines
- Enlarged pores
- Shallow scarring
- Loss of firmness
I start small and decide whether to add after seeing the face again a few weeks later.
Compared with i and Juvelook
i and Skin share the same 30 mg (25.5 + 4.5) formula. The i brochure highlights a 20 µm particle, sensitive skin and full-face use; Skin is presented as one vial per person for wrinkles, elasticity, pores and scars. The original Juvelook is 50 mg. All three are dermal.
Juvelook Skin FAQ
When was Juvelook Skin launched?
June 2026.
Skin vs Juvelook?
Skin is 30 mg and Juvelook 50 mg; same ratio, both dermal. Skin is sized for one vial per person.
What is Juvelook Skin for?
Overall skin quality in the dermis: wrinkles, elasticity, pores and scars.
Where can I get a Juvelook consultation in Daegu?
Miso Clinic is on the 4th floor of the Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82 53-428-2700. Weekdays 11:00–19:00, Saturdays 10:00–16:00, closed Sundays and public holidays. The clinic stocks the full Juvelook line (i, Skin, Juvelook, Volume 100, Volume and G).
Read next
Product pages
Product page: Juvelook — PDLLA with hyaluronic acid
Who wrote this
Written and reviewed by Lee Chi-Hak, MD, director of Miso Clinic, Daegu. The treatment standards and injection design set out here are the ones we use in practice.
| Medical director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Phone | +82-53-428-2700 |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Columns | All clinical columns |
| Reference library | All booster and device references |
References
- Juvelook Skin launch — Rapportian, 1 June 2026. 30 mg, injected into the dermis for wrinkles, elasticity, pores and scars; one vial per person; patented porous mesh structure.
- Manufacturer product page — juvelook.co.kr (VAIM Co., Ltd.). Juvelook I and Skin 30 mg, Juvelook 50 mg, Volume 100 100 mg, Volume and G 200 mg, all 85% PDLLA and 15% hyaluronic acid. Registered in Korea as a class IV medical device (tissue-repair material) for the temporary improvement of facial wrinkles in adults.
- Manufacturer brochures — VAIM Juvelook, Juvelook i and Juvelook G brochures (obtained by Miso Clinic, October 2026). Mean particle size i 20, Juvelook 24, Volume 40, G 65 µm; layer per product (i and Juvelook dermis, Volume and G subcutaneous); store below 30 °C, do not freeze; porous mesh-structured particles.
- Skin rejuvenation, 16 patients — Seo SB et al., J Cosmet Dermatol 2024;23(3):794–802, PMID 37969055. PDLLA with non-cross-linked HA, 2–3 sessions 4 weeks apart; fine wrinkles, texture, irregular pigmentation, telangiectasia and erythema all improved; half reported over 50% improvement; collagen and elastic fibres increased on histology.
- How Miso Clinic works — full Juvelook line in stock (confirmed by the director, 14–15 October 2026); concern, then layer, then product; start small and review after a few weeks; deep hollows shaped first with dissolvable hyaluronic acid filler; sagging addressed first with lifting; other options first under the eyes. Source of every “I” or “we” sentence in this column.
- Korean medical advertising law — Medical Service Act art. 56(2) and 27(3). No testimonials, before-and-after photos or prices appear here. Results and how long they last vary from person to person.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English